Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$729M |
| 2 |
Booking.com
BKNG
|
+$309M |
| 3 |
PepsiCo
PEP
|
+$294M |
| 4 |
Comcast
CMCSA
|
+$285M |
| 5 |
Netflix
NFLX
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$778M |
| 2 |
Walmart Inc
WMT
|
+$382M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
NetEase
NTES
|
+$344M |
| 5 |
Becton Dickinson
BDX
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.7% |
| 2 | Technology | 14.02% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.92% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Usana Health Sciences
USNA
$429M
| $168M | 0.18% |
1,961,466
+30,500
| +2% | +$2.36M |
|
102
AbbVie
ABBV
$465B
| $166M | 0.18% |
+1,755,656
| New | +$193M |
|
103
Regeneron Pharmaceuticals
REGN
$72.9B
| $166M | 0.18% |
482,470
-97,092
| -17% | -$33.8M |
|
104
Novartis
NVS
$304B
| $165M | 0.18% |
2,272,955
+357,787
| +19% | +$27.2M |
|
105
Johnson & Johnson
JNJ
$643B
| $165M | 0.18% |
1,284,399
-2,185,401
| -63% | -$295M |
|
106
Mettler-Toledo International
MTD
$28.1B
| $163M | 0.18% |
284,300
+74,200
| +35% | +$46.6M |
|
|
ECHO
107
EchoStar
ECHO
$24.9B
| $162M | 0.18% |
3,785,517
+141,910
| +4% | +$6.75M |
|
|
ORBK
108
DELISTED
Orbotech Ltd
ORBK
| $162M | 0.18% |
2,601,900
-40,900
| -2% | -$2.25M |
|
109
Charles River Laboratories
CRL
$11.6B
| $156M | 0.17% |
1,460,300
+61,600
| +4% | +$6.64M |
|
110
Northrop Grumman
NOC
$78B
| $155M | 0.17% |
444,400
+101,900
| +30% | +$34.1M |
|
|
RTN
111
DELISTED
Raytheon Company
RTN
| $155M | 0.17% |
715,900
-216,500
| -23% | -$44.8M |
|
112
Edison International
EIX
$30.7B
| $154M | 0.17% |
2,426,300
-684,100
| -22% | -$42.1M |
|
113
BCE
BCE
$20.3B
| $154M | 0.17% |
3,581,771
+1,559,471
| +77% | +$70.1M |
|
114
Lockheed Martin
LMT
$134B
| $153M | 0.17% |
+451,600
| New | +$154M |
|
115
Keurig Dr Pepper
KDP
$42.3B
| $152M | 0.17% |
1,285,900
+563,600
| +78% | +$62.5M |
|
116
Motorola Solutions
MSI
$73.1B
| $150M | 0.16% |
1,424,415
+613,000
| +76% | +$62.6M |
|
117
National Grid
NGG
$81.3B
| $149M | 0.16% |
2,993,441
+301,965
| +11% | +$14.7M |
|
118
Franco-Nevada
FNV
$40.6B
| $149M | 0.16% |
2,183,900
+360,400
| +20% | +$26.4M |
|
119
Dominion Energy
D
$62.1B
| $148M | 0.16% |
+2,193,000
| New | +$162M |
|
120
Labcorp
LH
$25.8B
| $147M | 0.16% |
1,060,875
+187,760
| +22% | +$27.6M |
|
121
RenaissanceRe
RNR
$13.9B
| $146M | 0.16% |
1,053,815
+185,700
| +21% | +$24.1M |
|
122
Monster Beverage
MNST
$95.6B
| $145M | 0.16% |
5,081,400
+635,600
| +14% | +$19.8M |
|
123
National Beverage
FIZZ
$3.05B
| $145M | 0.16% |
3,261,800
+459,600
| +16% | +$22.6M |
|
124
Dolby
DLB
$4.97B
| $145M | 0.16% |
2,281,500
-49,800
| -2% | -$3.2M |
|
125
Jazz Pharmaceuticals
JAZZ
$16.1B
| $145M | 0.16% |
958,400
-286,400
| -23% | -$42M |
|
Similar funds
Renaissance Technologies's Q1 2018 Portfolio in Review
As of Q1 2018, Renaissance Technologies held 3,782 positions worth $91.4B, up 0.81% from $90.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies's Q1 2018 filing shows 474 new, 1,646 increased, 1,191 reduced and 438 closed positions. Its largest new stake was Amazon: 10,199,100 shares worth $738M. The largest sale was ExxonMobil, an estimated $778M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2018 buy was Amazon: 10,199,100 shares worth $738M.
- Renaissance Technologies added most to Booking.com in Q1 2018, an estimated $309M increase.
- Renaissance Technologies's biggest Q1 2018 reduction was ExxonMobil, cutting an estimated $778M.
- Renaissance Technologies fully exited Marathon Petroleum in Q1 2018, selling an estimated $132M.
- Renaissance Technologies's ten largest holdings make up 9% of its $91.4B portfolio in Q1 2018.
- Renaissance Technologies opened 474 new positions and closed 438 in Q1 2018.
- Renaissance Technologies's portfolio value rose 0.81% quarter-over-quarter to $91.4B.
Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.